Lisa Swanson, MD: What’s New in Pediatric Dermatology at AAD 2025

Dr. Swanson highlights key developments presented at the AAD 2025 Annual Meeting, providing an overview of emerging therapies, clinical research, and treatment advances across several important pediatric dermatology conditions.

Her discussion focuses on the latest innovations affecting children with inflammatory, autoimmune, and vascular skin disorders, as well as how these developments may influence clinical practice.

Topics Covered

New treatment advances in pediatric Atopic Dermatitis
Emerging therapies for pediatric Psoriasis
Updates in the management of Alopecia Areata in children
Advances in Vitiligo treatment and repigmentation strategies
New insights into the care of Infantile Hemangioma

Explore Related Resources

MORE COVERAGE FROM THE 2025 AAD ANNUAL MEETING

Peter Lio, MD: Updates in AD and Diet

Dr. Lio discusses the complex relationship between diet and **Atopic Dermatitis (AD), addressing common patient questions, misconceptions, and concerns regarding dietary modifications. His presentation emphasizes

Emmy Graber, MD: New Efficacy Evidence for Acne and Rosacea Devices

Dr. Graber reviews emerging evidence supporting the use of energy-based devices for the treatment of Acne Vulgaris and Rosacea, highlighting how advances in laser and

Steve Daveluy, MD: Using Cryoinsufflation in Patients with Hidradenitis Suppurativa

Dr. Daveluy discusses practical techniques and clinical considerations for using cryoinsufflation in the treatment of Hidradenitis Suppurativa (HS). His presentation provides guidance on incorporating this

Christopher Bunick, MD, PhD: Clearing Up Questions Around Benzene in Benzoyl Peroxide Products

Dr. Bunick examines the ongoing discussion surrounding benzene contamination concerns in benzoyl peroxide (BPO) products, addressing questions about product safety, regulatory oversight, and best practices

Peter Lio, MD: Managing Itch in Patients with Cancer

Dr. Lio discusses strategies for addressing chronic itch (pruritus) in patients undergoing treatment for non-dermatologic cancers, a symptom that can significantly affect comfort, sleep quality,

Steve Daveluy, MD: Pharm to Table: How Medications and Diet Interact

Dr. Daveluy explores the important relationship between nutrition and dermatologic therapies, discussing how dietary choices can influence the effectiveness, absorption, and side effect profiles of

Jennifer Hsiao, MD: Recalcitrant Hidradenitis Suppurativa—What to do Next?

Dr. Jennifer Hsiao shares emerging strategies for treating recalcitrant hidradenitis suppurativa when standard therapies fail. Topics Covered: Management of treatment-resistant HS Emerging therapies and clinical

Christopher Bunick, MD, PhD: Antibiotic Update for Acne and Rosacea

Dr. Bunick provides a comprehensive update on using antibiotics for the treatment of acne and rosacea, including influences on gut health, antibiotic resistance, and efficacy

Iltefat Hamzavi, MD: Carbon Dioxide Laser for Hidradenitis Suppurativa

Dr. Hamzavi discusses key points from his presentation within the AAD 2025 session on surgical options for hidradenitis suppurativa.

Raj Chovatiya, MD, PhD: Chronic Hand Eczema at AAD 2025

Dr. Chovatiya discusses a symposium that he participated in at AAD 2025 focused on chronic hand eczema, reviewing prevalence, subtypes, morphology, and other important considerations

David Rosmarin, MD: How to Use Ruxolitinib Cream for Vitiligo

Dr. Rosmarin highlights his presentation from AAD 2025, in which he reviewed the optimal method for using ruxolitinib cream for vitiligo, touching on setting patient

Iltefat Hamzavi, MD: Surgical Options for Vitiligo

Dr. Hamzavi reviews the correct patient candidate for surgical therapy for vitiligo and the different options available, including punch grafting, suction blister epidermal grafting, and

Aaron Drucker MD, SCM, FRCPC: A Network Meta-analysis of Systemic Therapies for Atopic Dermatitis

In a summary of one of his talks from AAD 2025, Dr. Drucker discusses the results from a network meta-analysis that provides insight beyond the

Raj Chovatiya, MD, PhD: Social and Structural Disease-State Disparities in Inflammatory Skin Disease in Skin of Color

Dr. Chovatiya reviews one of his AAD sessions in which he discussed atopic dermatitis, hidradenitis suppurativa, and psoriasis in patients with skin of color. In

Melinda Gooderham, MSc, MD, FRCPC: JAK Inhibitors for Psoriasis

Dr. Gooderham discusses JAK inhibition in the context of psoriasis treatment, including comparing the important difference between competitive inhibition and allosteric inhibition when using JAKs

Julien Seneschal, MD, PhD: Immune Pathogenesis of Vitiligo

In an overview from his AAD 2025 presentation, Dr. Seneschal reviews important dimensions of the pathogenesis of vitiligo that necessitate maintenance therapy.

The AAD © Brand and Content are created by the American Academy of Dermatology “All rights reserved.” Any reproduction or republication is strictly prohibited without prior authorization.

The content of the 2025 AAD Annual Meeting (the “Content”) is copyrighted by the American Academy of Dermatology (“AAD”). The Works, JCADTV Coverage from the 2025 AAD Annual Meeting, are made up of coverage interviews and summaries and are created from the Content of the AAD under a license between the AAD and Matrix Medical Communications (“MATRIX MEDICAL COMMUNICATIONS”), and MATRIX MEDICAL COMMUNICATIONS is solely responsible for their content. The license of any content by the AAD does not constitute or imply endorsement of any company or its goods, services, or written work products, and the AAD is not responsible for any errors or omissions in the translation or reproduction of the content.

JCAD Archives